Vaxcyte PCVX
NASDAQ PCVX
$56.48 +0.43 (+0.77%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vaxcyte (PCVX) Sales of Property, Plant and Equipment (2021 - 2022)

Updated

Vaxcyte's Sales of Property, Plant and Equipment came in at $7,000 for FY2022, down 73.1% from $26,000 in FY2021.

Analysis

Vaxcyte (PCVX) Sales of Property, Plant and Equipment (2021 - 2022) Analysis & Trends

Going back to FY2018, Vaxcyte's Sales of Property, Plant and Equipment data covers 4 years.

  • Sales of Property, Plant and Equipment carries a four-year compound annual growth rate of 62.7% (FY2018 to FY2022).
  • The FY2022 figure represents the lowest annual Sales of Property, Plant and Equipment since FY2018.
  • Per Business Quant, earlier years put Sales of Property, Plant and Equipment at $26,000 in FY2021 (-48.0%), $50,000 in FY2020 and $1,000 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Vaxcyte 8.18 Bn 8.18 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 7,000.00
Dec 31, 2021 26,000.00
API Access

Vaxcyte Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=PCVX&period=max&api_key=YOUR_API_KEY